These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5143959)

  • 1. [Pathochemical bases for the treatment of parkinsonism].
    Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current medical treatment of Parkinsonian syndromes].
    Cincă I; Bulandra R; Serbănesco A; Ninosu N
    Rev Roum Neurol; 1973; 10(4):257-85. PubMed ID: 4767886
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience using veroshpiron in the combined therapy of parkinsonism].
    Vartanian KZ; Karimova MKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):14-8. PubMed ID: 3245369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy of parkinsonism.
    Yahr MD; Duvoisin RC
    N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of parkinsonism with L-dopa].
    Presthus J
    Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of parkinsonism with amantadine].
    Völler GW
    Dtsch Med Wochenschr; 1970 Apr; 95(17):934-7. PubMed ID: 5439551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Present-day treatment of parkinsonism in the aged].
    Siegfried J
    Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of the Umex treatment of parkinsonism patients in the initial stage of the disease].
    Fedorova NV; Glozman ZhM; Saltykova NM
    Ter Arkh; 1995; 67(10):75-7. PubMed ID: 8779116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism.
    Knutsson E; Mårtensson A; Meyerson BA; Risberg AM
    Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kr 339 in the treatment of parkinsonian tremor].
    Iivanainen M
    Duodecim; 1974; 90(8):590-6. PubMed ID: 4605767
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of parkinsonism. Current concepts.
    Yahr MD
    Med Clin North Am; 1972 Nov; 56(6):1377-92. PubMed ID: 4117524
    [No Abstract]   [Full Text] [Related]  

  • 12. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of therapy of parkinsonism].
    Walton JN
    Recenti Prog Med; 1971 Sep; 51(3):274-88. PubMed ID: 5171957
    [No Abstract]   [Full Text] [Related]  

  • 15. KR 339 in the treatment of Parkinsonian tremor.
    Iivanainen M
    Acta Neurol Scand; 1974; 50(4):469-77. PubMed ID: 4604665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the Parkinson syndrome with amantadine].
    Hartmann-von Monakow K
    Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
    Barjon P; Fourcade J; Mimran A; Charra B
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):187-92. PubMed ID: 5055013
    [No Abstract]   [Full Text] [Related]  

  • 20. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH
    Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.